Takeaway
- A multifaceted intervention program for patients with early-stage NSCLC that used race-specific data and real-time warnings of missed appointments or milestones from electronic health records monitored by a nurse navigator significantly reduced racial disparities in treatment rates.
Why this matters
- Studies show that black patients with NSCLC undergo curative treatment less often than white patients.
Study design
- Treatment rates of patients with early-stage NSCLC in an intervention program (n=360) were compared with retrospective (n=2841) and concurrent (n=597) control patients.
- Funding: National Cancer Institute; American Cancer Society.
Key results
- 31.7% of the intervention group, 15.9% of retrospective control patients, and 13.2% of concurrent control patients were black.
- Overall treatment rate was higher in the intervention group vs the retrospective and concurrent groups, regardless of race (96% vs 76% vs 83%, respectively; P<.001 for all>
- Overall treatment rates were higher with intervention for all patients:
- Intervention group: 96% for both blacks and whites.
- Retrospective group: 69% for blacks, 78% for whites.
- Concurrent group: 79% for blacks, 84% for whites.
- Receipt of surgery or radiation was lower for blacks in the retrospective group (aOR, 0.66; P=.001), but no racial disparity was seen in the intervention group (aOR for blacks, 2.1; P=.39).
Limitations
- Black patients were intentionally oversampled in the intervention group.
Only healthcare professionals with a Univadis account have access to this article.
You have reached your limit of complementary articles
Free Sign Up Available exclusively to healthcare professionals